Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-07
2009-11-24
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07622483
ABSTRACT:
Compounds of formulain free or salt or solvate form, whereAr is a group of formulaY is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
REFERENCES:
patent: 5510376 (1996-04-01), Epstein et al.
patent: 5578638 (1996-11-01), Brazzell et al.
patent: 5594027 (1997-01-01), Epstein et al.
patent: 5977154 (1999-11-01), Bell et al.
patent: 0 286 278 (1988-10-01), None
patent: 0 882 704 (1997-08-01), None
patent: 0 894 787 (1997-10-01), None
patent: WO 93 18007 (1993-09-01), None
patent: WO 99 09001 (1999-02-01), None
patent: WO 92/18461 (1992-10-01), None
patent: WO 93/15041 (1993-08-01), None
patent: 987425 (1998-08-01), None
Chemical Abstract AN 1994:217308, WO 93 18007, Tsuchiya et al.,(1993).
Banitt et al., Monofluoromethanesulfonanilides. A New Series of Bronchodilators, Journal of Medicinal Chemistry, vol. 17, No. 1 (1974).
Beattie David
Bruce Ian
Cuenoud Bernard
Fairhurst Robin A
Houghton Gregory C
Kifle Bruck
McAvoy Cozette M
Novartis AG
LandOfFree
β2-adrenoceptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with β2-adrenoceptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β2-adrenoceptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4123574